PA AAP Let's Talk Series: RSV and SARS CoV-2 Immunizations—Clinical and Office Implementation Updates 9.27.23
Pediatricians, Family Medicine Physicians, Residents, Nurse Practitioners, Nurses, Practice Staff
At the end of this session, participants will be able to:
- Understand the efficacy data of the new RSV immunization—Nirsevimab
- Understand the data and can implement recommendations regarding the upcoming SARS CoV-2 booster
- Store, code, and manage payment issues related to Nirsevimab
- Store, code, and manage payment issues related to the upcoming SARS CoV-2 booster
- Access the immunization program resources that are available at the Pennsylvania Chapter of the American Academy of Pediatrics
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses
Anish Raj, MD: Children’s Hospital of Philadelphia Child Abuse Pediatrics Fellowship, Brown University: Triple Board Residency Program Pediatric/Adult Psychiatry/Child Psychiatry.
Specialty certification American Board of Pediatrics. Academic Appointments: Johnson & Wales PA Program Adjunct Lecturer in Pediatrics.
Sarah Marino: BS Digital Communication. Community Prevention Educator, Mission Kids Child Advocacy Center.
Hannah Blair: Survivor Consultant and Lived Experience Expert
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.
Accreditation and credit designation
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and the Pennsylvania Chapter of the American Academy of Pediatrics. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 2.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 2.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 2.00 Attendance